Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia

12 Oct 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33046866
DOI: 10.1038/s41551-020-00625-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemiaPMID 33046866Read ↗

A transgenic zebrafish model expressing KIT-D816V recapitulates features of aggressive systemic mastocytosis.Semantic proximity Read ↗

Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.Semantic proximity Read ↗

The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model.Semantic proximity Read ↗

Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse modelSemantic proximity Read ↗

Cytotoxic Therapy–Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid NeoplasmsSemantic proximity Read ↗

Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms.Semantic proximity Read ↗

Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibitionSemantic proximity Read ↗

Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaSemantic proximity Read ↗

CAR-T Targeting of Mutant Calreticulin Establishes a Potentially Curative Stem Cell-Directed Therapy for Myeloproliferative NeoplasmsSemantic proximity Read ↗

<scp>KPT</scp>‐330 inhibitor of <scp>CRM</scp>1 (<scp>XPO</scp>1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of <scp>T</scp>‐cell acute lymphoblastic leukaemia and acute myeloid leukaemiaSemantic proximity Read ↗

Clinical implications of c-Kit mutations in acute myelogenous leukemia.Semantic proximity Read ↗

Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.